Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
sales of 55.14 billion Indian Rupees [US$773.67 million]
of which 33%
was Research Services),
Panacea Biotec Ltd
(4.57 billion Indian Rupees [US$64.08 million]
Hester Pharmaceuticals Limited
based in India
(1.78 billion Indian Rupees [US$24.98 million]
of which 73%
was Poultry Vaccines).
Atect Corp reported sales of ¥2.96 billion (US$27.90 million)
March of 2019.
increase of 10.7%
versus 2018, when the company's sales were ¥2.67 billion.
This was the fourth straight year of sales growth at Atect Corp.